Presentation TCT 2025 TCT 517: Safety and efficacy of sirolimus-coated drug balloons for percutaneous coronary interventions in a real-world cohort: Results from the Selution-SIROOP registry Presenter: Matthias Bossard October 27, 2025
Presentation TCT 2025 TCT 512: Outcomes of the PREVAIL DCB Study: Efficacy and Safety of Drug-Coated Balloons in Complex Coronary Lesions Presenter: Davit Baghdasaryan October 27, 2025
Presentation TCT 2025 TCT 510: Real-World Usage of a Prevail Paclitaxel-Coated Balloon Compared With Other Contemporary Drug-Coated Balloons for Long Coronary Artery Lesions Presenter: David Erlinge October 27, 2025
Presentation TCT 2025 TCT 672: Vascular healing of native coronary artery lesions following treatment with contemporary drug coated balloons: An optical coherence tomography sub-study from the SIROOP Registry Presenter: Matthias Bossard October 27, 2025
Presentation TCT 2025 TCT 511: Paclitaxel-Coated Balloons versus Newer-Generation Drug-Eluting Stents for De Novo Coronary Artery Lesions: A Meta-Analysis of Randomized Controlled Trials Presenter: Kamil Bujak October 27, 2025
Presentation TCT 2025 TCT 506: Impact of Pre-interventional Arterial Remodeling on Subsequent Vessel Behavior After Drug Coated Balloon Angioplasty: A Serial Intravascular Ultrasound Study Presenter: Allison Dumitriu Carcoana October 27, 2025
Presentation TCT 2025 TCT 508: Drug-Coated Balloon Versus Drug-Eluting Stent in De Novo Large Coronary Artery Disease: A Systematic Review and Meta-analysis. Presenter: Mohamed Elnady October 27, 2025
Presentation TCT 2025 TCT 509: Drug-Coated Balloon Versus Drug-Eluting Stent in De Novo Small Coronary Artery Disease: A Systematic Review and Meta-Analysis Presenter: Mohamed Elnady October 27, 2025
Presentation TCT 2025 TCT 502: Drug-Coated Balloons Versus Drug-Eluting Stents for Patients with Diffuse De Novo Coronary Artery Lesions: Insights from the REC-CAGEFREE I Trial Presenter: Yuehao Lv October 27, 2025
Presentation TCT 2025 TCT 501: Physiologic–Angiographic Discordance After Balloon Angioplasty within 15 minutes Presenter: Sodam Jung October 27, 2025
Presentation TCT 2025 TCT 503: Impact of sex on outcomes in patients treated with drug-coated balloons versus drug-eluting stents for de novo coronary artery lesions: Insights from the REC-CAGEFREE I trial Presenter: Ping Wang October 27, 2025
Presentation TCT 2025 TCT 504: Comparison of Drug Coated Balloon versus Drugs Eluting Stent Angioplasty in Acute Coronary Syndromes: A Systematic Review and Meta-Analysis Presenter: Kyriakos Dimitriadis October 27, 2025
Presentation TCT 2025 TCT 505: Long-Term Efficacy of Drug Coated Balloon versus Drug Eluting Stent Angioplasty in Acute Coronary Syndromes: A Systematic Review and Meta-Analysis Presenter: Kyriakos Dimitriadis October 27, 2025
Presentation TCT 2025 TCT 500: Clinical Outcomes of Patients With ST-Elevation Myocardial Infarction Treated With Drug-coated Balloons, Hybrid Strategies, or Drug-eluting Stents Presenter: Nancy Virginia October 27, 2025
News Conference News TCT 2025 Sirolimus-Coated Balloon Meets Mark in De Novo Lesions and ISR: SELUTION Michael O'Riordan October 26, 2025
Presentation TCT 2025 TCT 1825: Post-CABG Hybrid PCI in Subacute Multi-Graft Failure Presenter: Sujatha Vipperla October 26, 2025
Presentation TCT 2025 TCT 1824: Going Beyond Metal: The Treatment of a Highly Calcified Long LAD Lesion With Rotatripsy and Sirolimus-Coated Balloon in a Patient With Low Ejection Fraction and High-Bleeding Risk Presenter: Tuomas T. Rissanen October 26, 2025
Presentation TCT 2025 TCT 1823: Drug-Coated Balloon Treatment Despite an Angiographic Dissection to Avoid Dual Antiplatelet Therapy in a Patient Needing Vascular Surgery in Short Time Presenter: Marco Luciano Rossi October 26, 2025